Syndromes Without a Name Bring Labs an Uphill Battle
In an era when genetic and genomic testing are theoretically affordable and accessible, why do so many patients remain undiagnosed?
In an era when genetic and genomic testing are theoretically affordable and accessible, why do so many patients remain undiagnosed?
From - Diagnostic Testing & Emerging Technologies
The Xpert HCV Viral Load test (Cepheid, Sunnyvale, Calif.) for hepatitis C virus (HCV) has good accuracy for detecting viral RNA using whole blood from a finger stick…
From - Diagnostic Testing & Emerging Technologies
The United States is falling behind national goals to identify patients unaware of their positive HIV status and link them to care…
From - Diagnostic Testing & Emerging Technologies
Smartphone push-alert notification of troponin laboratory results allow physicians to discharge patients seen in the…
From - Diagnostic Testing & Emerging Technologies
New research suggests that potential shifts might occur in diabetes-related testing, including potential increased use of…
From - Diagnostic Testing & Emerging Technologies
Since 2013 when the U.S. Food and Drug Administration (FDA) effectively stopped direct-to-consumer personal genomic testing, there has been pent up demand among healthy individuals for…
From - Diagnostic Testing & Emerging Technologies
Also at the ACMG meeting, researchers from Illumina (San Diego, Calif.) reported on a pilot project conducted at the San Diego Blood Bank where…